Researchers from the Chinese Academy of Sciences in Beijing recently reported intriguing new evidence for a possible mouse origin of the Omicron variant. Their paper, posted on the BioRxiv preprint server, was quickly picked ...
Three epidemic or pandemic coronaviruses—SARS-CoV, MERS-CoV, & SARS-CoV-2—have spilled over from animals to cause deadly illness in humans in the past 20 years. Virus researchers are determined to discover a means to ...
Aug 6, 2021
4
598
(Medical Xpress)—Recent scientific papers from China suggest a vigilant watch should be kept on the development of bird flu viruses, as a new strain has been identified and previously known viruses have been shown capable ...
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein. This key protein enables the human ...
Jan 13, 2013
0
0
Recent SARS-CoV-2 variants such as BA.4 and BA.5 developed abilities missing from the first omicron variants that allowed them to overcome humans' innate immunity, according to research from UCL.
Jan 16, 2024
0
39
Gene therapy adeno-associated viruses (AAVs)—viruses that can be engineered to deliver DNA to target cells—are unlikely to cause cancer-triggering insertions in humans or monkeys and may contribute to long-term efficacy, ...
Nov 6, 2023
0
17
Allogeneic invariant natural killer T cells (allo-iNKTs) from a healthy donor have been shown to have therapeutic effects in treatment-resistant cancers and improve survival from COVID-19-related acute respiratory failure ...
Oct 20, 2023
0
24
Scientists studying how poxviruses evade natural defenses in human cells have identified a new approach to treatment that may be more durable than current treatments.
Aug 9, 2023
0
26
New research from the University of Copenhagen suggests that a portion of the Danish population has a composition of gut microbes that, on average, extracts more energy from food than do the microbes in the guts of their ...
Dec 27, 2022
0
131
Structural details of an attractive drug target in coronaviruses that could be used against SARS-CoV-2 and in future pandemics have been published today in eLife.
Nov 22, 2022
0
66
